COVID Vaccination and Age-Stratified All-Cause Mortality Risk
DOI:
https://doi.org/10.56098/rbvsmw07Keywords:
adverse events, COVID-19 vaccines, ecological regression, medical ethics, SARS-CoV-2 , vaccine safety, COVID-19 gene therapy products, all-cause mortality, COVID-19 infection rate, COVID-19 mortality, risk-benefit ratio, vaccine-induced mortality rateAbstract
Accurate estimates of the rates of COVID vaccine-induced severe adverse events and deaths per some standard of population size are critical for risk-benefit ratio analyses of vaccination and boosters against SARS-CoV-2 coronavirus in different age groups. However, existing surveillance studies are not designed to reliably estimate life-threatening events, or vaccine-induced mortality risks. Here, regional variations in the vaccination rates were used to predict all-cause mortality and non-COVID deaths in subsequent time periods using two independent, publicly available datasets from the US and Europe (month- and week-level resolutions, respectively). Vaccination correlated negatively with European mortality 6-20 weeks post-injection, while vaccination predicted all-cause mortality 0-5 weeks post-injection in almost all age groups and with an age-related temporal pattern consistent with the US vaccine rollout. Results from fitted regression slopes (p < 0.05 corrected for false discovery rate) suggest a US national average vaccination mortality rate (VMR) of 0.04% (0.0244, 0.0474 95% CI) and higher VMR with age (lower bound estimates of VMR=0.005% (0.0028, 0.0080 95% CI) in ages 0-17 increasing to 0.06% (0.0108, 0.0859 95% CI) in ages >75 years), and 146K to 187K vaccine-associated US deaths between February and August, 2021. Notably, adult vaccination correlated with increased subsequent mortality of unvaccinated younger people (<18, US; <15, Europe), possibly reflecting adverse effects indirectly caused by shedding of vaccine components. Comparing our estimates with the CDC-reported vaccine-induced mortality risk (0.002%) suggests VAERS deaths are underreported by a factor of 20, consistent with known VAERS under-ascertainment bias. Comparing our age-stratified VMRs with published age-stratified coronavirus infection fatality rates suggests the risks of the COVID vaccines and boosters outweigh the benefits in children, young adults, and older adults with low occupational risk, or with previous coronavirus exposure. Our findings raise important questions about current COVID mass vaccination strategies and warrant further investigation and review.
References
Aarstad, J., & Kvitastein, O. A. (2023). Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality? Asian Pacific Journal of Health Sciences, 10(1), Article 1. https://doi.org/10.21276/apjhs.2023.10.1.6
Agrawal, A. S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.-H., Couch, R. B., & Tseng, C.-T. K. (2016). Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Human Vaccines & Immunotherapeutics, 12(9), 2351–2356. https://doi.org/10.1080/21645515.2016.1177688
Alessandria, M., Malatesta, G., Di Palmo, G., Cosentino, M., & Donzelli, A. (2024). All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data. F1000Research, 13, 886. https://doi.org/10.12688/f1000research.154058.2
Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The American Journal of Case Reports, 22, e932946. https://doi.org/10.12659/AJCR.932946
Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2021). Three cases of acute venous thromboembolism in females following vaccination for COVID-19. Journal of Vascular Surgery. Venous and Lymphatic Disorders, S2213-333X(21)00392-9. https://doi.org/10.1016/j.jvsv.2021.07.009
Arbel, R., Hammerman, A., Sergienko, R., Friger, M., Peretz, A., Netzer, D., & Yaron, S. (2021). BNT162b2 Vaccine Booster and Mortality Due to Covid-19. The New England Journal of Medicine, 385(26), 2413–2420. https://doi.org/10.1056/NEJMoa2115624
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020). A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature, 584(7821), 353–363. https://doi.org/10.1038/s41586-020-2538-8
Axfors, C., & Ioannidis J.P.A. Infection fatality rate of COVID-19 in community-dwelling elderly populations. (2022). Eur J Epidemiol. Mar;37(3):235-249. https://doi.org/10.1007/s10654-022-00853-w
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., McGettigan, J., Khetan, S., Segall, N., Solis, J., Brosz, A., Fierro, C., Schwartz, H., Neuzil, K., Corey, L., … COVE Study Group. (2021). Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England Journal of Medicine, 384(5), 403–416. https://doi.org/10.1056/NEJMoa2035389
Baggs, J., Gee, J., Lewis, E., Fowler, G., Benson, P., Lieu, T., Naleway, A., Klein, N. P., Baxter, R., Belongia, E., Glanz, J., Hambidge, S. J., Jacobsen, S. J., Jackson, L., Nordin, J., & Weintraub, E. (2011). The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics, 127 Suppl 1, S45-53. https://doi.org/10.1542/peds.2010-1722H
Bardosh, K., Krug, A., Jamrozik, E., Lemmens, T., Keshavjee, S., Prasad, V., Makary, M. A., Baral, S., & Høeg, T. B. (2024). COVID-19 vaccine boosters for young adults: A risk benefit assessment and ethical analysis of mandate policies at universities. Journal of Medical Ethics, 50(2), 126–138. https://doi.org/10.1136/jme-2022-108449
Beattie, K. A. (2021). Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries. https://www.researchgate.net/publication/356248984_Worldwide_Bayesian_Causal_Impact_Analysis_of_Vaccine_Administration_on_Deaths_and_Cases_Associated_with_COVID-19_A_BigData_Analysis_of_145_Countries
Bell, D. (2023)). COVID Vaccines Were Never Safe for Pregnant Women, Pfizer’s Own Data Show. The Defender: Children’s Health Defense. https://childrenshealthdefense.org/defender/pfizer-covid-vaccine-pregnancy/
Block, J. (2023). Is the US’s Vaccine Adverse Event Reporting System broken? BMJ, 383, p2582. https://doi.org/10.1136/bmj.p2582 Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute Allergic Reactions to mRNA COVID-19 Vaccines. JAMA, 325(15), 1562–1565. https://doi.org/10.1001/jama.2021.3976
Boros, L. G., Kyriakopoulos, A. M., Brogna, C., Piscopo, M., McCullough, P. A., & Seneff, S. (2024). Long‐lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID ‐19 vaccination. Pharmacology Research & Perspectives, 12(3), e1218. https://doi.org/10.1002/prp2.1218
Brogna, C., Cristoni, S., Marino, G., Montano, L., Viduto, V., Fabrowski, M., Lettieri, G., & Piscopo, M. (2023). Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms. PROTEOMICS – Clinical Applications, 17(6), 2300048. https://doi.org/10.1002/prca.202300048
Brown, C. M., Vostok, J., Johnson, H., Burns, M., Gharpure, R., Sami, S., Sabo, R. T., Hall, N., Foreman, A., Schubert, P. L., Gallagher, G. R., Fink, T., Madoff, L. C., Gabriel, S. B., MacInnis, B., Park, D. J., Siddle, K. J., Harik, V., Arvidson, D., … Laney, A. S. (2021). Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings—Barnstable County, Massachusetts, July 2021. MMWR. Morbidity and Mortality Weekly Report, 70(31), 1059–1062. https://doi.org/10.15585/mmwr.mm7031e2
Cardozo, T., & Veazey, R. (2021). Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. International Journal of Clinical Practice, 75(3), e13795. https://doi.org/10.1111/ijcp.13795
Chande, A. (2020). COVID-19 Event Risk Assessment Planning Tool. Retrieved August 16, 2021, from https://covid19risk.biosci.gatech.edu/
Chandler, R. W. (2025). Light chain disorders indicative of immune disorders and/or cancers associated with the COVID-19 infections and injections. International Journal of Vaccine Theory, Practice, and Research, 4(1), 1557–1581. https://doi.org/10.56098/mmk5wh51
Chitwood, M. H., Russi, M., Gunasekera, K., Havumaki, J., Klaassen, F., Pitzer, V. E., Salomon, J. A., Swartwood, N. A., Warren, J. L., Weinberger, D. M., Cohen, T., & Menzies, N. A. (2021). Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model (p. 2020.06.17.20133983). https://doi.org/10.1101/2020.06.17.20133983
Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021). BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. The New England Journal of Medicine, 384(15), 1412–1423. https://doi.org/10.1056/NEJMoa2101765
Dowd, E. (Director). (2022, May 6). Ed Dowd Assesses the COVID Numbers [Video recording]. https://rumble.com/v13rixu-ed-dowd-assesses-the-covid-numbers.html
Dowd, E., Becker, G. de, & Kennedy, R. F., Jr. (2024). “Cause Unknown”: The Epidemic of Sudden Deaths in 2021 & 2022 & 2023. Children’s Health Defense Books. https://www.skyhorsepublishing.com/9781510776395/cause-unknown/
European Medicines Agency. (n.d.). Assessment report: COVID-19 mRNA vaccine (nucleoside-modified). https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf
Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports, 14(9), e245218. https://doi.org/10.1136/bcr-2021-245218
Fung, K., Jones, M., & Doshi, P. (2024). Sources of bias in observational studies of covid-19 vaccine effectiveness. Journal of Evaluation in Clinical Practice, 30(1), 30–36. https://doi.org/10.1111/jep.13839
Grixti, J. M., Chandran, A., Pretorius, J. https://doi.org/10.1111/jep.13839H, et al. The clots removed from ischaemic stroke patients by mechanical thrombectomy are amyloid in nature. Published online November 4, 2024:2024.11.01.24316555. https://doi:10.1101/2024.11.01.24316555
Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., Zaccardi, F., Watkinson, P., Shankar-Hari, M., Doidge, J., Harrison, D. A., Griffin, S. J., Sheikh, A., & Coupland, C. A. C. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: Self-controlled case series study. BMJ (Clinical Research Ed.), 374, n1931. https://doi.org/10.1136/bmj.n1931
Hulscher, N. (2025, May 23). NEW STUDY - Circulating Spike Protein Detectable 709 Days after COVID-19 mRNA Injection. https://www.thefocalpoints.com/p/new-study-circulating-spike-protein
Hulscher, N., Alexander, P. E., Amerling, R., Gessling, H., Hodkinson, R., Makis, W., Risch, H. A., Trozzi, M., & McCullough, P. A. (2024). A systematic review of autopsy findings in deaths after COVID-19 vaccination. Science, Public Health Policy and the Law. 5.2019-2024 https://publichealthpolicyjournal.com/a-systematic-review-of-autopsy-findings-in-deaths-after-covid-19-vaccination/
Hunter, P. R. (2021). Thrombosis after covid-19 vaccination. BMJ (Clinical Research Ed.), 373, n958. https://doi.org/10.1136/bmj.n958
Ioannidis, J. P. A. (2021). Infection fatality rate of COVID-19 inferred from seroprevalence data. Bulletin of the World Health Organization, 99(1), 19-33F. https://doi.org/10.2471/BLT.20.265892
Jara, A., Undurraga, E. A., González, C., Paredes, F., Fontecilla, T., Jara, G., Pizarro, A., Acevedo, J., Leo, K., Leon, F., Sans, C., Leighton, P., Suárez, P., García-Escorza, H., & Araos, R. (2021). Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. New England Journal of Medicine, 385(10), 875–884. https://doi.org/10.1056/NEJMoa2107715
King, W. C., Rubinstein, M., Reinhart, A., & Mejia, R. J. (2021). Time trends and factors related to COVID-19 vaccine hesitancy from January-May 2021 among US adults: Findings from a large-scale national survey (p. 2021.07.20.21260795). https://doi.org/10.1101/2021.07.20.21260795
Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., Donahue, J. G., Kharbanda, E. O., Naleway, A., Nelson, J. C., Xu, S., Yih, W. K., Glanz, J. M., Williams, J. T. B., Hambidge, S. J., Lewin, B. J., Shimabukuro, T. T., DeStefano, F., & Weintraub, E. S. (2021). Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. https://doi.org/10.1001/jama.2021.15072
Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19? Toxicology Reports, 8, 1665–1684. https://doi.org/10.1016/j.toxrep.2021.08.010
Lai, C.-C., Ko, W.-C., Chen, C.-J., Chen, P.-Y., Huang, Y.-C., Lee, P.-I., & Hsueh, P.-R. (2021). COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Review of Vaccines, 20(8), 1027–1035. https://doi.org/10.1080/14760584.2021.1949294
Lataster, R. (2024). How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID-19 vaccines. Journal of Evaluation in Clinical Practice, 30(3), 453–458. https://doi.org/10.1111/jep.13962
Lazarus, R., & Klompas, M. (2011.). Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS). https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020). Assessing the age specificity of infection fatality rates for COVID-19: Systematic review, meta-analysis, and public policy implications. European Journal of Epidemiology, 35(12), 1123–1138. https://doi.org/10.1007/s10654-020-00698-1
Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., Rubin, C., Freedman, L., Kreiss, Y., & Regev-Yochay, G. (2021). Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2114583
Lewnard, J. A., Hong, V. X., Patel, M. M., Kahn, R., Lipsitch, M., & Tartof, S. Y. (2022). Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California (p. 2022.01.11.22269045). medRxiv. https://doi.org/10.1101/2022.01.11.22269045
Lyons-Weiler, J. (2020). Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Journal of Translational Autoimmunity, 3, 100051. https://doi.org/10.1016/j.jtauto.2020.100051
Merchant, H. (2021). Might post-injection distribution of CoViD vaccines to the brain explain the rare fatal events of cerebral venous sinus thrombosis (CVST)? BMJ (Clinical Research Ed.), 373, n958. https://pure.hud.ac.uk/en/publications/might-post-injection-distribution-of-covid-vaccines-to-the-brain-
Murthy, B. P. (2021). COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years—United States, December 14, 2020–July 31, 2021. MMWR. Morbidity and Mortality Weekly Report, 70. https://doi.org/10.15585/mmwr.mm7035e1
Nyström S., Hammarström P. Amyloidogenesis of SARS-CoV-2 spike protein. J Am Chem Soc. 2022;144(20):8945-8950. https://doi:10.1021/jacs.2c03925
Office of the Commissioner (2021, June 25). Coronavirus (COVID-19) Update: June 25, 2021. FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
Ogata, A. F., Cheng, C.-A., Desjardins, M., Senussi, Y., Sherman, A. C., Powell, M., Novack, L., Von, S., Li, X., Baden, L. R., & Walt, D. R. (2021). Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clinical Infectious Diseases, ciab465. https://doi.org/10.1093/cid/ciab465
Oller, J., & Santiago, D. (2022). All cause mortality and COVID-19 injections: evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”. International Journal of Vaccine Theory, Practice, and Research, 2(2), 301–319. https://doi.org/10.56098/ijvtpr.v2i2.42
Osborne-Crowley, L. (2021, January 30). ‘There is a lot of distrust’: Why women in their 30s are hesitant about the Covid vaccine. The Guardian. https://www.theguardian.com/society/2021/jan/31/there-is-a-lot-of-distrust-why-women-in-their-30s-are-hesitant-about-the-covid-vaccine
Oster, M. E., Shay, D. K., Su, J. R., Gee, J., Creech, C. B., Broder, K. R., Edwards, K., Soslow, J. H., Dendy, J. M., Schlaudecker, E., Lang, S. M., Barnett, E. D., Ruberg, F. L., Smith, M. J., Campbell, M. J., Lopes, R. D., Sperling, L. S., Baumblatt, J. A., Thompson, D. L., … Shimabukuro, T. T. (2022). Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA, 327(4), 331–340. https://doi.org/10.1001/jama.2021.24110
Pantazatos, S. (2021). Vaccine mandates are not based on sound science: They are harmful and should be lifted as soon as possible. https://researchers.one/articles/21.08.00008
Pantazatos, S., & Seligmann, H. (2021a). COVID vaccination and age-stratified all-cause mortality risk.
https://doi.org/10.13140/RG.2.2.28257.43366/1
Pantazatos, S., & Seligmann, H. (2021b). Supplementary Tables and Figures—Google Drive for “COVID vaccination and age-stratified all-cause mortality risk.” Retrieved February 20, 2022, from https://docs.google.com/spreadsheets/d/e/2PACX-1vSp5F0ITHHwVUrQ208wANGsTeZyPr3-OT34k2wylIQAmSu1afjPkYibEFqL3QXIJddo2nuOWleWDTSE/pubhtml
Pantazatos, S. (2025, March 16). Does COVID vaccination reduce COVID deaths in ages 65 and older? [Substack newsletter]. Spiro’s Newsletter. https://telemimesis.substack.com/p/did-covid-vaccination-reduce-covid
Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A. C., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2022). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine, 28(2), Article 2. https://doi.org/10.1038/s41591-021-01630-0
Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2021). Risk of myocarditis following sequential COVID-19 vaccinations by age and sex (p. 2021.12.23.21268276). medRxiv. https://doi.org/10.1101/2021.12.23.21268276
Peters†, S. E., Newman†, J., Ray, H., Thorp, J. A., Parotto, T., Hooker, B., McDyer, D., Murphy, L., Stricker, R. B., McDonnell, M., Mills, P. J., Gieck, W., Northrup, C., & Equally, †The two lead authors contributed. (2024). Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1435–1461. https://doi.org/10.56098/tp99wn15
Pfizer Confidential. (n.d.). SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Overview of Pharmacokinetic Test. https://files.catbox.moe/0vwcmj.pdf
Rancourt, D. (2022, February 25). Nature of the COVID-era public health disaster in the USA from all-cause mortality and socio-geo-economic and climatic data. https://vaccinesafety.info/2022/02/25/2021-10-25-nature-of-the-covid-era-public-health-disaster-in-the-usa-from-all-cause-mortality-and-socio-geo-economic-and-climatic-data-denis-rancourt-2/,
Rancourt, D., Baudin, M., & Mercier, J. (2022, August 2). COVID-Period Mass Vaccination Campaign. https://denisrancourt.ca/entries.php?id=116&name=2022_08_02_covid_period_mass_vaccination_campaign_and_public_health_disaster_in_the_https://www.bitchute.com/video/jJg7E2ajQN2J/usa
Rancourt, D., Baudin, M., & Mercier, J. (Directors). (2023, November 19). Staggering 17 million deaths after COVID jab rollouts [Video recording]. https://www.bitchute.com/video/jJg7E2ajQN2J/
Rancourt, D. G., Baudin, M., Hickey, J., & Mercier, J. (2023, September 17). COVID-19 vaccine-associated mortality in the Southern Hemisphere. CORRELATION: Research in the Public Interest. https://correlation-canada.org/covid-19-vaccine-associated-mortality-in-the-southern-hemisphere/
Rogers, C., Thorp, J., Cosgrove, K., & McCullough, P. (2024). COVID-19 Vaccines: A risk factor for cerebral thrombotic syndromes. International Journal of Innovative Research in Medical Science 9(11):621–27. https://doi:10.23958/ijirms/vol09-i11/1982
Rose, J., & Crawford, M. (2021). Estimating the number of COVID vaccine deaths in America. https://downloads.regulations.gov/CDC-2021-0089-0024/attachment_1.pdf
Rose, J., & McCullough, P. TEMPORARY REMOVAL: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products—ScienceDirect. (n.d.). Retrieved February 7, 2022, from https://doi.org/10.1016/j.cpcardiol.2021.101011
Santiago, D. (2022). Playing Russian Roulette with every COVID-19 injection: The deadly global game. International Journal of Vaccine Theory, Practice, and Research, 2(2), 619–650. https://doi.org/10.56098/ijvtpr.v2i2.36
Santiago, D., & Oller, J. W. (2023). Abnormal clots and all-cause mortality during the pandemic experiment: five doses of COVID-19 vaccine are evidently lethal to nearly all Medicare participants. International Journal of Vaccine Theory, Practice, and Research, 3(1), 847–890. https://doi.org/10.56098/ijvtpr.v3i1.73
Santiago, D. (2024). A closer look at N1-Methylpseudouridine in the modified mRNA injectables. International Journal of Vaccine Theory, Practice, and Research 3(2):1345–66. https://doi:10.56098/5azda593.
Seligmann, H. (2021, May 9). Expert evaluation on adverse effects of the Pfizer-COVID-19 vaccination. https://www.researchgate.net/publication/351441506_Expert_evaluation_on_adverse_effects_of_the_Pfizer-COVID-19_vaccination
Seligmann, H., & Taravel, P. (2025a). COVID19 injections: Direct/indirect (shedding) effects on cardiovascular diseases. https://doi.org/10.13140/RG.2.2.27270.69445
Seligmann, H., & Taravel, P. (2025b). Shedding by young teens fuels cancers mainly in COVID19-injected adult females. https://doi.org/10.13140/RG.2.2.13433.79204
Seligmann, H., & Taravel, P. (2025c). Shedding of COVID19 injections: For each 10-14-y-old teen injected until mid-2021, two additional adult women, not men, died of cancer in 2021 vs 2020. https://doi.org/10.13140/RG.2.2.11170.34243
Seligmann, H., & Taravel, P. (2025d). Vaccine shedding (alloeffects) of COVID19 injections associate with European all-cause mortality (Jan 2021-Oct 2023). https://www.researchgate.net/publication/387705416_Vaccine_shedding_alloeffects_of_COVID19_injections_associate_with_European_all-cause_mortality_Jan_2021-Oct_2023
Seneff, S., & Nigh, G. (2021). worse than the disease? reviewing some possible unintended consequences of the mRNA vaccines Against COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(1), Article 1. https://ijvtpr.com/index.php/ijvtpr/article/view/23
Sharff, K. A., Dancoes, D. M., Longueil, J. L., Johnson, E. S., & Lewis, P. F. (2021). Risk of Myopericarditis following COVID-19 mRNA vaccination in a Large Integrated Health System: A Comparison of Completeness and Timeliness of Two Methods (p. 2021.12.21.21268209). medRxiv. https://doi.org/10.1101/2021.12.21.21268209
Skidmore, M. (2023). The role of social circle COVID-19 illness and vaccination experiences in COVID-19 vaccination decisions: An online survey of the United States population. BMC Infectious Diseases, 23(1), 51. https://doi.org/10.1186/s12879-023-07998-3
Skidmore, M., & Alfaro, F. (2024). Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1055–1084. https://doi.org/10.56098/h1mv5a64
Sorli, A. S. (2025). The discrepancy between the number of saved lives with COVID-19 vaccination and statistics of Our World Data. Journal of Clinical Trials, 15(32), 1–4. https://www.longdom.org/open-access-pdfs/the-discrepancy-between-the-number-of-saved-lives-with-covid19-vaccination-and-statistics-of-our-world-data.pdf
Sun, C. L. F., Jaffe, E., & Levi, R. (2022). Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Scientific Reports, 12(1), 6978. https://doi.org/10.1038/s41598-022-10928-z
Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination. The American Journal of Cardiology, 156, 129–131. https://doi.org/10.1016/j.amjcard.2021.06.047
Thorp, J. A., Rogers, C., Deskevich, M. P., Tankersley, S., Benavides, A., Redshaw, M. D., & McCullough, P. A. (2022). COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function (2022090430). J Am Physicians Surg 2022;28:28–34. https://www.jpands.org/vol28no1/thorp.pdf https://www.preprints.org/manuscript/202209.0430/v1.
Thorp, J. A., Rogers, C., Deskevich, M. P., Tankersley, S., Benavides, A., Redshaw, M. D., & McCullough, P. A. (2023). Increased risk of fetal loss after COVID-19 vaccination. Human Reproduction, 38(12), 2536. https://doi.org/10.1093/humrep/dead204
VAERS - Data. (2021). Retrieved August 16, 2021, from https://vaers.hhs.gov/data.html
Vojdani, A., Vojdani, E., & Kharrazian, D. (2020). Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Frontiers in Immunology, 11, 617089. https://doi.org/10.3389/fimmu.2020.617089
VSD Data Sharing Program Guidelines | Vaccine Safety | CDC. (2020, August 31). https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/data-sharing-guidelines.html
Walensky, R. P. (2021). Statement from CDC Director Rochelle P. Walensky, MD, MPH on today’s MMWR: Media statement for immediate release: Friday, July 30, 2021. Retrieved August 8, 2025, from https://stacks.cdc.gov/view/cdc/108440
Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., Zhou, Y., Du, L., & Li, F. (2020). Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. Journal of Virology, 94(5), e02015-19. https://doi.org/10.1128/JVI.02015-19
Wen, J., Cheng, Y., Ling, R., Dai, Y., Huang, B., Huang, W., Zhang, S., & Jiang, Y. (2020). Antibody-dependent enhancement of coronavirus. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 100, 483–489. https://doi.org/10.1016/j.ijid.2020.09.015
Xu, S. (2021). COVID-19 Vaccination and Non–COVID-19 Mortality Risk—Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021. MMWR. Morbidity and Mortality Weekly Report, 70. https://doi.org/10.15585/mmwr.mm7043e2
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Spiro P. Pantazatos, Hervé Seligman
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.